Abstract
A diagnostic drug containing manganese chloride tetrahydrate as a major ingredient is available since 2006. It is used in magnetic resonance imaging as a negative contrast medium for magnetic resonance cholangiopancreatography of the gastrointestinal tract. However, there is no report regarding interaction between manganese and new quinolone antibacterials. We investigated the interactions between new quinolone antibacterials and a diagnostic drug containing manganese in vitro. We evaluated the rate of formation of chelate complex by reacting new quinolone antibacterials (levofloxacin, ofloxacin, ciprofloxacin) with a diagnostic drug containing manganese. The EC50 values of the formation of chelate complex for levofloxacin, ofloxacin, and ciprofloxacin were 5.14 ± 0.14, 5.29 ± 0.14, and 0.96 ± 0.04 mM, respectively. The rates of formation of chelate complex by levofloxacin, ofloxacin, and ciprofloxacin in a reaction with the diagnostic drug were 17.0, 18.9, and 55.5 % in clinical condition, respectively. Our results suggest that a complex of each antibacterial and manganese was formed, with ciprofloxacin causing the strongest interaction. In addition, our findings indicate that the degree of interaction may be an important problem in clinical settings with concomitant administration of a new quinolone antibacterial and diagnostic drug containing manganese.
Similar content being viewed by others
References
Miyazaki H, Kitadai S, Kaneko K (2002) Effects of magnesium ion and aluminium ion on the urinary excretion of levofloxacin and sparfloxacin. Jpn J Pharm Health Care Sci 28:126–129
Mizuki Y, Fujiwara I, Yamaguchi T (1996) Pharmacokinetic interactions related to the chemical structures of fluoroquinolones. J Antimicrob Chemother 37(Suppl A):41–55
Nakano M, Yamamoto M, Arita T (1978) Interactions of aluminum, magnesium, and calcium ions with nalidixic acid. Chem Pharm Bull 26:1505–1510
Shiba K (1994) Example of combinations checked at prescription-inhibition of absorption with the metal cationic components. J Ther 76:2285–2291
Shiba K, Sakai O, Shimada J, Okazaki O, Aoki H, Hakusui H (1992) Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans. Antimicrob Agents Chemother 36:2270–2274
Tanaka M, Kurata T, Fujisawa C, Ohshima Y, Aoki H, Okazaki O, Hakusui H (1993) Mechanistic study of inhibition of levofloxacin absorption by aluminum hydroxide. Antimicrob Agents Chemother 37:2173–2178
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hosono, M., Yokoyama, H., Takayanagi, R. et al. Interactions between new quinolone antibacterials and diagnostic drug containing manganese. Eur J Drug Metab Pharmacokinet 38, 255–259 (2013). https://doi.org/10.1007/s13318-013-0120-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13318-013-0120-6